Enlivex Announces Receipt of Delisting Notice from Nasdaq; Intends to Appeal
Enlivex received a Nasdaq delisting notice because its closing bid price stayed below the $1.00 minimum for 30 consecutive business days. Because the company already effected a reverse split within the past 12 months, it is not entitled to the usual 180-day compliance period; it has filed for a Nasdaq Hearings Panel appeal, which stays any suspension pending the hearing.
Key figures
- Reverse split ratio
- 1-for-16
- Noncompliance window
- 30 consecutive business days prior to October 22, 2026
- Minimum bid price requirement
- $1.00
AI analysis
Red flags5 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.